A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for ...

An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy. ...

AI-based computer-aided detection devices during colonoscopy was associated with higher adenoma detection rates than usual care, a pragmatic, quality improvement trial shows.

Trauma-focused therapy is associated with reduced PTSD symptom severity and increased remission in patients with co-occurring psychosis, a new randomized trial shows.

This roundup highlights a number of FDA actions in June related to therapeutics for psychiatric illness. For information on approvals in other specialties during the first quarter of 2026, see our FDA ...

In Canada, ED overcrowding, particularly with older adults, is a healthcare system failure that must be addressed across ...

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with ...

High-resolution impedance manometry identifies physiologic evidence of reflux in many patients with obesity whose ...

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart ...

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

Roflumilast 0.05% (Zoryve), a topical phosphodiesterase-4 inhibitor, is currently approved for treating mild-to-moderate AD in children aged 2 years or older; it was approved for ...

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether ...